Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07062770 · ClinicalTrials.gov registry record · NA
Assessment of Circuit Rebreathing During CPAP Therapy
A NA study of Obstructive Sleep Apnea (OSA), sponsored by Brigham and Women's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 13
- Enrollment target
- 1
- Study location
NCT07062770: Recruiting NA study of Obstructive Sleep Apnea (OSA), sponsored by Brigham and Women's Hospital.
NCT07062770 is a NA study of Obstructive Sleep Apnea (OSA) that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 13 participants, below the 591-participant average among 12 other Obstructive Sleep Apnea (OSA) trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07062770, a NA study of Obstructive Sleep Apnea (OSA), is actively recruiting participants, sponsored by Brigham and Women's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this research is to better understand how different CPAP mask designs affect airflow and rebreathing of exhaled carbon dioxide (CO₂) during sleep in individuals with obstructive sleep apnea (OSA).
Primary Outcome
Difference in FiO2 between 23L/s vs 13L/s exhaust flow at 5 cmH2O PAP.
Conditions Studied
Interventions
- DEVICE Continuous positive airway pressure (CPAP)
- OTHER Mask exhaust port flow
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2025-05-27 |
| Est. Completion | 2025-12-01 |
| Phase | NA |
What NCT07062770 shows while recruiting
NCT07062770 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 591-participant average among 12 other Obstructive Sleep Apnea (OSA) trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Obstructive Sleep Apnea (OSA) appearing as the primary indexed condition, and to 2 interventions - of which Continuous positive airway pressure (CPAP) is the first listed.
NCT07062770 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07062770 about?
NCT07062770 is a clinical study titled "Assessment of Circuit Rebreathing During CPAP Therapy". The goal of this research is to better understand how different CPAP mask designs affect airflow and rebreathing of exhaled carbon dioxide (CO₂) during sleep in individuals with obstructive sleep apnea (OSA).
What is the current status of trial NCT07062770?
This trial is currently recruiting. It is a NA study. The enrollment target is 13 participants. The study started on 2025-05-27. Estimated completion is 2025-12-01.
What conditions does trial NCT07062770 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea (OSA).
What interventions are being tested in trial NCT07062770?
The interventions under investigation include: Continuous positive airway pressure (CPAP) (DEVICE), Mask exhaust port flow (OTHER).
Who is sponsoring clinical trial NCT07062770?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07062770 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea (OSA)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07062770's enrollment target sits among peer trials
13 11th of 12 higher than 1 of 12 other Obstructive Sleep Apnea (OSA) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obstructive Sleep Apnea (OSA) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IOA Preventing Occlusal Changes With MAD Use
RECRUITING · NA
-
Telehealth for Sleep Apnea: Effectiveness, Implementation, and Cost in the Military Health System
RECRUITING · NA
-
The Impact of Technology in Obstructive Sleep Apnea Myofunctional Therapy
ACTIVE NOT RECRUITING · NA
-
Pilot Study of the Comparison of the Upper Airway Dynamics of Oronasal vs Nasal Masks With PAP Treatment
COMPLETED · NA
-
Differences in Efficacy Between Nasal and Oronasal Masks in the Treatment of OSA With CPAP
COMPLETED · NA
-
Inspire UAS High Apnea Hypopnea Index (AHI)/High Body Mass Index (BMI) Post-Approval Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI